Education
About Us
Working with TipRanks
Follow Us
Epigenomics AG (GB:0QXH)
:0QXH
| Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 6.07M | $ 697.00K | $ 871.00K | $ 1.07M | $ 1.64M |
| Operating Income | $ -4.16M | $ -10.11M | $ -15.10M | $ -13.29M | $ -9.86M |
| EBITDA | $ -1.94M | $ -11.07M | $ -13.99M | $ -12.57M | $ -9.93M |
| Net Income | $ -2.43M | $ -11.69M | $ -17.02M | $ -12.69M | $ -10.23M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 24.66M | $ 6.80M | $ 13.99M | $ 21.83M | $ 19.77M |
| Total Debt | $ 460.00K | $ 683.00K | $ 913.00K | $ 0.00 | $ 6.54M |
| Net Debt | $ -22.50M | $ -3.84M | $ -10.12M | $ -17.05M | $ -7.20M |
| Total Liabilities | $ 2.54M | $ 2.93M | $ 4.36M | $ 3.21M | $ 9.20M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -4.19M | $ -9.59M | $ -13.63M | $ -10.46M | $ -10.16M |
| Operating Cash Flow | $ -4.15M | $ -9.57M | $ -13.51M | $ -10.35M | $ -9.58M |
| Investing Cash Flow | |||||
| Financing Cash Flow |
Epigenomics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.